Innate Immune Response to Monkeypox Virus Infection: Mechanisms and Immune Escape
- PMID: 39137733
- PMCID: PMC11521483
- DOI: 10.1159/000540815
Innate Immune Response to Monkeypox Virus Infection: Mechanisms and Immune Escape
Abstract
Background: The reemergence of monkeypox virus (Mpox, formerly monkeypox) in 2022 in non-endemic countries has raised significant concerns for global health due to its high transmissibility and mortality rate. A major challenge in combating Mpox is its ability to evade the host's innate immune system, the first line of defense against viral infections.
Summary: Mpox encodes various proteins that interfere with key antiviral pathways and mechanisms, such as the nuclear factor kappa B signaling, cytokine production, complement and inflammasome activation, and chemokine binding. These proteins modulate the expression and function of innate immune mediators, such as interferons, interleukins, and Toll-like receptors, and impair the recruitment and activation of innate immune cells, such as natural killer cells. By suppressing or altering these innate immune responses, Mpox enhances its replication and infection in the host tissues and organs, leading to systemic inflammation, tissue damage, and organ failure.
Key messages: This study reveals new insights into the molecular and cellular interactions between Mpox and the host's innate immune system. It identifies potential targets and strategies for antiviral interventions, highlighting the importance of understanding these interactions to develop effective treatments and improve global health responses to Mpox outbreaks.
Keywords: Immune response; Immunity; Innate; Mpox; Reemerging viral.
© 2024 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Monkeypox (Mpox) vs. Innate immune responses: Insights into evasion mechanisms and potential therapeutic strategies.Cytokine. 2024 Nov;183:156751. doi: 10.1016/j.cyto.2024.156751. Epub 2024 Sep 7. Cytokine. 2024. PMID: 39244831 Review.
-
Mpox global health emergency: Insights into the virus, immune responses, and advancements in vaccines PART I: Insights into the virus and immune responses.Asian Pac J Allergy Immunol. 2024 Sep;42(3):181-190. doi: 10.12932/AP-111024-1945. Asian Pac J Allergy Immunol. 2024. PMID: 39417767 Review.
-
A comprehensive review of monkeypox virus and mpox characteristics.Front Cell Infect Microbiol. 2024 Mar 6;14:1360586. doi: 10.3389/fcimb.2024.1360586. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38510963 Free PMC article. Review.
-
Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral Immune Responses by Suppressing IRF3- and NF-κB-Mediated Transcription.J Virol. 2019 May 15;93(11):e00181-19. doi: 10.1128/JVI.00181-19. Print 2019 Jun 1. J Virol. 2019. PMID: 30867312 Free PMC article.
-
Inducible Guanylate-Binding Protein 7 Facilitates Influenza A Virus Replication by Suppressing Innate Immunity via NF-κB and JAK-STAT Signaling Pathways.J Virol. 2021 Feb 24;95(6):e02038-20. doi: 10.1128/JVI.02038-20. Print 2021 Feb 24. J Virol. 2021. PMID: 33408175 Free PMC article.
Cited by
-
Characterization of the Monkeypox Virus [MPX]-Specific Immune Response in MPX-Cured Individuals Using Whole Blood to Monitor Memory Response.Vaccines (Basel). 2024 Aug 26;12(9):964. doi: 10.3390/vaccines12090964. Vaccines (Basel). 2024. PMID: 39339995 Free PMC article.
References
-
- Shafaati M, Zandi M. State-of-the-art on monkeypox virus: an emerging zoonotic disease. Infection. 2022;50(6):1425–30. - PubMed
-
- Brown B. Immunopathogenesis of orthopoxviridae: insights into immunology from smallpox to Monkeypox (Mpox); 2023.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical